Loading...
NPI 1124106786 · Great Falls, MT · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Mark Ozog is a ophthalmology physician provider located in Great Falls, Montana. This profile covers 16 Medicare and 8 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Mark Ozog |
| Address | 1417 9th St S Ste 100 |
| City | Great Falls |
| State | MT |
| ZIP | 59405 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | November 1, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.1M |
| Medicaid | $77.9K |
Payer mix is heavily Medicare-weighted: the provider reports Total Medicare revenue of $1.1M versus Total Medicaid revenue of $77.9K, so while the practice bills both payers it is effectively Medicare-dominant in scale. Medicaid activity is present but small relative to Medicare, and strategic or capacity decisions are likely driven by Medicare volumes and reimbursement patterns.
Medicare revenue is highly concentrated in intravitreal drug and injection services: the precomputed top 3 Medicare codes account for 85.3% of the provider's Medicare revenue, with J2777 and J0178 alone making up the largest shares. This concentration points to a revenue model centered on high-cost retinal therapeutics rather than a broad surgical cataract or comprehensive ophthalmology mix.
The specific top Medicare procedures reinforce a medical-retina / injection-clinic profile: J2777 (faricimab) generated $469.8K (41.4% of provider Medicare revenue), J0178 (aflibercept) generated $443.8K (39.1%), and 67028 (intravitreal injection) contributed $54.7K (4.8%). Together these codes indicate routine administration of anti-VEGF and newer retina biologics as the core service line, supported by injection procedure coding for each treatment episode.
Competitive standing on Medicare is modest-to-typical for the major drug codes: J2777 ranks #661 of 2039 providers nationally (68th percentile; typical, unremarkable volume) and J0178 ranks #1713 of 3204 (46th percentile; typical, unremarkable volume). The provider is not a national outlier or dominant center for these agents, but maintains a measurable mid-level presence for faricimab and aflibercept.
Operational volumes show meaningful office and new-patient exam activity that supplements injection work: Medicare 92004 (comprehensive new patient exam) is listed as 96th percentile and labeled notably above typical national volume, and 99212 (established office visit) is 98th percentile and labeled notably above typical national volume. These patterns suggest sustained clinic throughput for new evaluations and straightforward follow-ups in addition to injection sessions.
Medicaid revenue is also concentrated but reflects a different mix: the precomputed top 3 Medicaid codes account for 80.5% of Medicaid revenue, driven by 92014 ($27.2K, 34.9%), J0178 ($22K, 28.3%), and 92004 ($13.4K, 17.2%). This indicates Medicaid dollars come mainly from comprehensive exams and a smaller volume of aflibercept injections rather than the same faricimab-dominated mix seen in Medicare.
Competitive standing in-state for Medicaid is limited on several retinal codes: J0178 is billed (50 claims) but ranks #3 of 4 providers in-state (33rd percentile; typical, unremarkable volume), and 67028 ranks #11 of 11 providers in-state (0th percentile; typical, unremarkable volume). Those rankings imply the provider is not a leading Medicaid injector for some intravitreal procedures within Montana and may face low in-state peer adoption or billing on these specific Medicaid-covered items.
Provider tenure is long-established: the NPI was enumerated on 2006-11-01 (~20 years ago), indicating sustained presence in the market. This length of tenure, combined with concentrated anti-VEGF revenue and above-typical exam visit volumes, is consistent with a mature ophthalmology practice that operates an active injection clinic alongside ongoing outpatient care.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 16,200 | $30 | $469.8K |
| J0178 | Injection, aflibercept, 1 mg | 650 | $690 | $443.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 560 | $100 | $54.7K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 630 | $90 | $53.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 940 | $30 | $28.3K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 50 | $430 | $21.5K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 200 | $100 | $20.8K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 430 | $40 | $18.4K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 170 | $60 | $10.6K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 20 | $270 | $6.1K |
Showing 1–10 of 16
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
16 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 9 | 20 | 460 | $680 | $663.4K |
| J2777 | 4 | 10 | 10,170 | $30 | $351.2K |
| 66984 | 64 | 120 | 50 | $490 | $78.1K |
| 67028 | 10 | 20 | 390 | $90 | $73.7K |
| 92014 | 20 | 170 | 190 | $80 | $22.7K |
| 66821 | 46 | 70 | 50 | $220 | $18.3K |
| 92012 | 18 | 50 | 80 | $60 | $11.9K |
| J9035 | 7 | 10 | 100 | $50 | $10.3K |
| 92136 | 30 | 30 | 270 | $30 | $8.9K |
| 92134 | 11 | 160 | 100 | $30 | $7.8K |
Showing 1–10 of 16
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 350 | $80 | $27.2K |
| J0178 | Injection, aflibercept, 1 mg | 50 | $440 | $22K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 140 | $90 | $13.4K |
| 92015 | The provider determines the process of determining if a patient's vision is less than 20/20 and by what amount so that corrective lenses or contact lenses can be prescribed and produced. | 430 | $10 | $5.6K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 310 | $10 | $4.3K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 140 | $30 | $4.3K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 10 | $50 | $640 |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 20 | $20 | $290 |
How this provider's Medicaid billing volume and revenue compare to other Montana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Montana median
8 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 82 | 130 | 600 | $90 | $120.9K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 82 | 120 | 440 | $110 | $96K |
| J0178 | Injection, aflibercept, 1 mg | 3 | 10 | 60 | $490 | $80.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 11 | 10 | 810 | $50 | $52.4K |
| 92015 | The provider determines the process of determining if a patient's vision is less than 20/20 and by what amount so that corrective lenses or contact lenses can be prescribed and produced. | 82 | 130 | 1,300 | $20 | $37K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 13 | 20 | 1,300 | $20 | $28.6K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 33 | 30 | 270 | $10 | $12.6K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 222 | 240 | 170 | $1 | $10.3K |
Other providers in the same ZIP code as Mark Ozog, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.